What is the appropriate dose of regular insulin for a patient with hyperglycemia (glucose level of 500 mg/dL)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Regular Insulin Dosing for Severe Hyperglycemia (500 mg/dL)

For a patient with a blood glucose of 500 mg/dL, administer intravenous regular insulin at an initial bolus dose of 0.15 units/kg followed by a continuous infusion at 0.1 units/kg/hour (typically 5-7 units/hour for adults). 1

Approach to Severe Hyperglycemia Management

Initial Assessment

  • Determine if the patient has diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS)
  • Check for hypokalemia (K+ < 3.3 mEq/L) before starting insulin therapy
  • Assess hydration status and initiate appropriate fluid replacement

Insulin Administration Protocol

For Intravenous Administration (Preferred Method):

  1. Initial bolus: 0.15 units/kg of regular insulin IV
  2. Continuous infusion: 0.1 units/kg/hour (typically 5-7 units/hour for adults)
  3. Monitoring and adjustment:
    • If glucose does not decrease by at least 50 mg/dL in the first hour, check hydration status
    • If hydration is adequate, double the insulin infusion rate hourly until achieving a steady glucose decline of 50-75 mg/dL per hour 1

For Subcutaneous Administration (If IV Access Unavailable):

  • For mild DKA only: Give "priming" dose of regular insulin at 0.4-0.6 units/kg, with half as IV bolus and half as subcutaneous injection
  • Follow with 0.1 unit/kg subcutaneously every hour 1

Special Considerations

Transition to Subcutaneous Insulin

Once blood glucose reaches 250-300 mg/dL:

  • Start basal-bolus insulin regimen
  • Continue IV insulin for 1-2 hours after first subcutaneous dose to ensure adequate plasma insulin levels
  • Avoid abrupt discontinuation of IV insulin 1

Sliding Scale for Subcutaneous Regular Insulin

For patients unable to receive IV insulin with glucose of 500 mg/dL:

  • Use 20 units of regular insulin subcutaneously (based on sliding scale of 5 units for every 50 mg/dL above 150 mg/dL) 1
  • Monitor glucose every 4-6 hours

Monitoring Parameters

  • Check blood glucose every 1-2 hours until stable, then every 2-4 hours
  • Monitor electrolytes, especially potassium
  • For DKA, monitor resolution of ketosis (preferably using β-hydroxybutyrate measurements)

Pitfalls to Avoid

  1. Delayed treatment: Severe hyperglycemia requires prompt intervention to prevent complications
  2. Inadequate monitoring: Frequent glucose checks are essential to avoid hypoglycemia
  3. Premature discontinuation of IV insulin: Continue IV insulin for 1-2 hours after initiating subcutaneous insulin to prevent rebound hyperglycemia
  4. Neglecting fluid status: Adequate hydration is critical for insulin effectiveness and patient safety
  5. Relying on urine ketones: Blood β-hydroxybutyrate measurement is preferred for monitoring ketosis resolution 1

Remember that patients with severe hyperglycemia often have significant fluid deficits requiring aggressive rehydration alongside insulin therapy. The goal is to achieve a steady glucose decline while avoiding too rapid correction, which can lead to complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.